After finishing at $10.00 in the prior trading day, Relay Therapeutics Inc (NASDAQ: RLAY) closed at $10.16, up 1.60%. In other words, the price has increased by $+0.16 from its previous closing price. On the day, 1100659 shares were traded. RLAY stock price reached its highest trading level at $10.79 during the session, while it also had its lowest trading level at $10.00.
Ratios:
Our goal is to gain a better understanding of RLAY by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 25.44 and its Current Ratio is at 25.44. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 19, 2023, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $29.
On April 13, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on April 13, 2023, with a $29 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 29 when Bergstrom Donald A sold 3,178 shares for $9.64 per share. The transaction valued at 30,636 led to the insider holds 530,878 shares of the business.
Catinazzo Thomas sold 2,005 shares of RLAY for $19,328 on Jan 29. The Chief Financial Officer now owns 341,846 shares after completing the transaction at $9.64 per share. On Jan 29, another insider, Adams Brian, who serves as the Chief Legal Officer of the company, sold 1,929 shares for $9.64 each. As a result, the insider received 18,596 and left with 327,738 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 1.33B and an Enterprise Value of 636.16M. For the stock, the TTM Price-to-Sale (P/S) ratio is 52.16 while its Price-to-Book (P/B) ratio in mrq is 1.72. Its current Enterprise Value per Revenue stands at 24.90 whereas that against EBITDA is -1.70.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $19.54, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is 10.34, while the 200-Day Moving Average is calculated to be 10.05.
Shares Statistics:
The stock has traded on average 1.07M shares per day over the past 3-months and 1.52M shares per day over the last 10 days, according to various share statistics. A total of 127.46M shares are outstanding, with a floating share count of 91.07M. Insiders hold about 30.58% of the company’s shares, while institutions hold 71.68% stake in the company. Shares short for RLAY as of Jan 31, 2024 were 9.45M with a Short Ratio of 8.82, compared to 12.01M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 7.41% and a Short% of Float of 9.62%.
Earnings Estimates
Its stock is currently analyzed by 10 different market analysts. On average, analysts expect EPS of -$0.74 for the current quarter, with a high estimate of -$0.67 and a low estimate of -$0.86, while EPS last year was -$0.78. The consensus estimate for the next quarter is -$0.74, with high estimates of -$0.64 and low estimates of -$0.85.
Analysts are recommending an EPS of between -$2.57 and -$3.46 for the fiscal current year, implying an average EPS of -$2.98. EPS for the following year is -$2.9, with 10 analysts recommending between -$2.31 and -$4.02.
